Osteoporosis
Osteoporosis is a disease characterized by low bone mass and loss of bone tissue that may lead to weak and fragile bones. If you have osteoporosis, you have an increased risk for fractured bones (broken bones), particularly in the hip, spine, and wrist.
See the complete A-Z list of all the Osteoporosis related information or browse the current list of select resources.
Osteoporosis Related Resources
Osteoporosis Articles
- Hormone Replacement and Osteoporosis
- X-Rays
- Treatment of Osteoporosis
- Prevention of Osteoporosis
- Bone Loss
- Osteopenia
- Compression Fracture (Vertebral) vs. Herniated Disc (Slipped Disc)
- Bone Mineral Density Tests
- Fall Prevention and Osteoporosis
- Osteoporosis in Men
- Osteoporosis Medications
- Paget's Disease
- Osteoporosis and Calcium
- Osteoporosis FAQ
- Osteoporosis
Osteoporosis Medications
- alendronate and cholecalciferol (Fosamax Plus D) (Fosamax Plus D)
- ibandronate (oral/injection) (Boniva) (Boniva)
- teriparatide (Forteo) (Forteo)
- risedronate (Actonel, Atelvia) (Actonel)
- raloxifene (oral) (Evista) (Evista)
- alendronate (Binosto, Fosamax) (Fosamax)
- pamidronate (Aredia)
- etidronate (Didronel) (Didronel)
- calcitonin injection (Calcimar, Miacalcin) (Miacalcin)
Osteoporosis Images and Slideshows
Osteoporosis Quizzes
Osteoporosis News
- Bone Loss After Gastric Bypass Surgery
- Dairy Plus Vitamin D Needed to Preserve Bone Density in the Old
- Soy Protein May Protect Against Osteoporosis
- Black Tea Tied to Fewer Fractures in Older Women
- The Dangers of Thinning Bones as Men Age
- FDA Panel: Long-Used Osteoporosis Drug Too Risky
- Moderate Drinking May Help Older Women's Bones
- Vitamin D and Calcium Pills: Task Force Report
- FDA OKs Generic Boniva for Bone Loss
- Metal-on-Metal Hip Implants Have Higher Fail Rates
- Osteoporosis Medication Linked to Unusual Thigh Fractures
- Bone Density at Age 67 May Predict Later Bone Health
- Study: Bone Drugs May Increase Longevity of Replaced Joints
- FDA: Osteoporosis Drug Reclast Ups Kidney Failure Risk
- New Evidence of Fracture Risk From Bone Drugs